Press Releases

Intrexon to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference

GERMANTOWN, Md., May 15, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced management will participate at the Bank of America Merrill Lynch 2017 Healthcare Conference at Encore at the Wynn, Las Vegas, Nevada. 

  • Andrew Last, Ph.D., Chief Operating Officer of Intrexon, will present on Tuesday, May 16th, at 5:00 p.m. Pacific Time.  A live webcast of Dr. Last's presentation will be available on the Investors section of Intrexon's website at http://investors.dna.com/events.  A replay will be available for 30 days following the event.
  • Thomas D. Reed, Ph.D., Founder and Chief Science Officer of Intrexon, will participate in the panel discussion 'Synthetic Biology, the Promises & Challenges of Engineering Biology' on Tuesday, May 16th, at 3:00 p.m. Pacific Time.

Intrexon Corporation logo. (PRNewsFoto/Intrexon Corporation)

About Intrexon Corporation: 
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet.  Intrexon's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn.

Trademarks
Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.

Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

For more information regarding Intrexon Corporation, contact:

Investor Contact:

Christopher Basta

Vice President, Investor Relations

Tel: +1 (561) 410-7052

investors@intrexon.com

Corporate Contact:

Marie Rossi, Ph.D.

Director, Technical Communications

Tel: +1 (301) 556-9850

publicrelations@intrexon.com

 

SOURCE Intrexon Corporation


print email rss